Condition
Anatomic Stage IIIB Breast Cancer AJCC v8 clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Anatomic Stage IIIB Breast Cancer AJCC v8 clinical trials that are recruiting, at sites in 4 countries (most in United States (8), Puerto Rico (2), Mexico (1)). By phase: Phase 3 (2), Phase 1 (2), Phase 1/2 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 4Countries
Newest Anatomic Stage IIIB Breast Cancer AJCC v8 clinical trials
All recruiting trials (8)
-
Personalized tumor vaccine with checkpoint inhibitors for triple negative breast cancer
This phase I trial will test whether a personalized tumor membrane vesicle (TMV) vaccine, given alone or with pembrolizumab or ipilimumab, can boost immune response and help control disease in adults with triple negative breast cancer.
-
Shorter chemotherapy and immunotherapy for early-stage triple negative breast cancer
This study is testing whether a shorter treatment plan of chemotherapy and immunotherapy without certain strong drugs can help people with early-stage triple negative breast cancer do better than the usual longer treatment.
-
Comparing pembrolizumab to observation for early-stage triple-negative breast cancer after chemotherapy
This study tests whether a drug called pembrolizumab can help prevent the return of early-stage triple-negative breast cancer after chemotherapy, compared to just keeping an eye on patients without extra treatment.
-
Using minoxidil to treat hair loss in breast cancer patients on endocrine therapy
This study is testing if a hair loss treatment called minoxidil, given either as a foam or a pill, can help women with breast cancer who are losing their hair due to cancer therapy.
-
Personalized vaccine combined with pembrolizumab for advanced solid tumors
This study is testing a new personalized cancer vaccine combined with pembrolizumab to see if it helps people with advanced solid tumors fight their cancer better.
-
Combining Tumor Treating Fields with Cabozantinib or Pembrolizumab and Nab-Paclitaxel for Advanced Solid Tumors
This study is testing a new treatment that combines tumor treating fields with two different cancer drugs to see if it helps people with advanced solid tumors in the abdomen or chest.
-
Combining Olaparib with Cediranib or AZD6738 for Advanced Breast Cancer with BRCA Mutations
This study is testing if combining the drugs olaparib with either cediranib or AZD6738 can help women with advanced breast cancer that has BRCA mutations feel better after they’ve already tried other treatments.
-
A tool to help patients decide on contralateral prophylactic mastectomy for breast cancer
This study tests if an online tool can help women newly diagnosed with breast cancer make better choices about having a preventive mastectomy on the other breast.
Related topics
Quick answers
How many Anatomic Stage IIIB Breast Cancer AJCC v8 clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (8 trials), Puerto Rico (2 trials), Mexico (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 1: 2, Phase 1/2: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.